Proprietary Pipeline

Advancing our proprietary pipeline

Our breast cancer vaccine is the most advanced proprietary program, and has demonstrates promising preclinical results. Additionally, ExpreS2ion collaborates with Evaxion A/S on a cytomegalovirus vaccine, utilising a proprietary AI-driven technology platform. We also explore several undisclosed assets with shorter timelines and cost-effective paths to value creation.